Job for Pharmacist in AMR Surveillance at IGIMS

IGIMS was established on 19th November 1983, as an autonomous organisation on the pattern of All India Institute of Medical Sciences, New Delhi.

The objective was to provide super specialty medical facilities in Bihar. On 27th January 1983 Cabinet approved the completion of this massive project in 4 phases within a span of six (6) years.

According to the decision of State Government, 130.20 Acres of land was transferred to IGIMS.

WALK-IN-INTERVIEW FOR PHARMACIST ON CONTRACTUAL BASIS (06 MONTHS) UNDER RESEARCH PROJECT IN AMR SURVEILLANCE AT IGIMS, PATNA FUNDED BY NCDC

Post : Pharmacist

No of Posts : 01

Pay : Rs 18,000 / Month Consolidated

Qualification :  12 Pass in Science subjects.
– Diploma in Pharmacy from recognised Institution/ Board
Desirable : Experience in dispensing and/or storage and dispending of drugs in a reputed hospital or institution or in a drugs store or a pharmaceutical concern.

Age : Below 40 Years

Candidates having requisite qualification & experience with a copy of complete BIO-DATA with their original papers and its photocopy with two passport size photographs may come for walk-in interview on date and time mentioned above.

All Qualifications and degrees must be obtained from a recognized University / Board / lnstitution.

Only Experience from recognized Institutions is acceptable. No TA/DA is allowed for appearing in the interview.

If the performance of candidate is not found satisfactory, his/her contract will be terminated within a month. The decision of Director, IGIMS, Patna will be final.

Walk-in interview of eligible Indian Citizen for appointment of above post has been fixed on 05th Oct. 2021 at 11:00 AM in the Director chamber

INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES
SHEIKHPURA, PATNA – 800014 (Bihar, India)

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices